176 related articles for article (PubMed ID: 19429859)
1. The epidermal growth factor receptor: a link between inflammation and liver cancer.
Berasain C; Perugorria MJ; Latasa MU; Castillo J; Goñi S; Santamaría M; Prieto J; Avila MA
Exp Biol Med (Maywood); 2009 Jul; 234(7):713-25. PubMed ID: 19429859
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and liver cancer: new molecular links .
Berasain C; Castillo J; Perugorria MJ; Latasa MU; Prieto J; Avila MA
Ann N Y Acad Sci; 2009 Feb; 1155():206-21. PubMed ID: 19250206
[TBL] [Abstract][Full Text] [Related]
3. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 in hepatocellular carcinoma.
Wu T
Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB and liver carcinogenesis.
Arsura M; Cavin LG
Cancer Lett; 2005 Nov; 229(2):157-69. PubMed ID: 16125305
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation.
Urtasun R; Latasa MU; Demartis MI; Balzani S; Goñi S; Garcia-Irigoyen O; Elizalde M; Azcona M; Pascale RM; Feo F; Bioulac-Sage P; Balabaud C; Muntané J; Prieto J; Berasain C; Avila MA
Hepatology; 2011 Dec; 54(6):2149-58. PubMed ID: 21800344
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation and hepatocellular carcinoma.
Alison MR; Nicholson LJ; Lin WR
Recent Results Cancer Res; 2011; 185():135-48. PubMed ID: 21822824
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of hepatocellular carcinoma.
Aravalli RN; Steer CJ; Cressman EN
Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
10. Amphiregulin: a new growth factor in hepatocarcinogenesis.
Berasain C; Castillo J; Perugorría MJ; Prieto J; Avila MA
Cancer Lett; 2007 Aug; 254(1):30-41. PubMed ID: 17321672
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
[TBL] [Abstract][Full Text] [Related]
12. Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells.
Robitaille G; Christin MS; Clément I; Senécal JL; Raymond Y
Arthritis Rheum; 2009 Sep; 60(9):2805-16. PubMed ID: 19714638
[TBL] [Abstract][Full Text] [Related]
13. Skin toxicity caused by EGFR antagonists-an autoinflammatory condition triggered by deregulated IL-1 signaling?
Rodeck U
J Cell Physiol; 2009 Jan; 218(1):32-4. PubMed ID: 18781585
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, a key event in cancer development.
Lu H; Ouyang W; Huang C
Mol Cancer Res; 2006 Apr; 4(4):221-33. PubMed ID: 16603636
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic.
Voiculescu M; Winkler RE; Moscovici M; Neuman MG
J Gastrointestin Liver Dis; 2008 Sep; 17(3):315-22. PubMed ID: 18836626
[TBL] [Abstract][Full Text] [Related]
16. The role of inflammation and liver cancer.
Bishayee A
Adv Exp Med Biol; 2014; 816():401-35. PubMed ID: 24818732
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
18. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
19. [Tumours and inflammatory liver diseases].
Wittekind Ch
Verh Dtsch Ges Pathol; 2005; 89():163-8. PubMed ID: 18035686
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of disease: Inflammatory mediators and cancer prevention.
Mann JR; Backlund MG; DuBois RN
Nat Clin Pract Oncol; 2005 Apr; 2(4):202-10. PubMed ID: 16264935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]